ARTICLE | Company News
Indevus, Teva deal
September 29, 2008 7:00 AM UTC
Indevus granted Teva an exclusive, worldwide license to pagoclone. The cyclopyrrolone GABA receptor agonist is in Phase II testing to treat stuttering with a Phase IIb trial expected to start in 1Q0...